1. MedMarket Diligence, Tissue engineering, cell therapy and transplantation: products, technologies & market opportunities, Worldwide, 2009–2018, Foothill Ranch, CA, USA: MedMarket Diligence, LLC, Report No. S520 (2010).
2. M Rao, ML Condic, Musings on genome medicine: is there hope for ethical and safe stem cell therapeutics?, Genome Med, 1, 70 (2009).
3. DA Brindley, BC Reeve, WA Sahlman, et al., The impact of market volatility on the cell therapy industry, Cell Stem Cell, 9, 397 (2011).
4. P Kemp, History of regenerative medicine: looking backwards to move forwards, Regen Med, 1, 653 (2006).
5. B Husing, B Buhrlen, S Gaisser, Human tissue engineered products; Today’s Markets and Future Prospects, Final Report for Work Package 1: Analysis of the actual market situation-Mapping of industry and products, Fraunhofer Institute for Systems and Innovation Research, Karlsruhe, Germany (2003).